首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells.
【24h】

Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells.

机译:肝实质细胞中肿瘤坏死因子-α和白介素-6上调高亲和力的嘧啶优先核苷转运蛋白浓缩核苷转运蛋白1。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Concentrative nucleoside transporter 1 (CNT1), a high affinity transporter for pyrimidine nucleosides, is responsible for their Na(+)-dependent concentrative uptake into hepatocytes. Though CNT1 protein amounts increase in rat liver soon after partial hepatectomy, the physiological regulators of CNT1 expression have not yet been identified. METHODS: Rat hepatoma cell lines and hepatocytes isolated from fetuses and adult rats were used to identify single agents able to up-regulate CNT1 expression and activity in liver. TNF-alpha receptor-I (TNFRI) and IL-6 knock-out mice were also used to study CNT1 regulation in vivo. RESULTS: TNF-alpha and IL-6 independently induced CNT1 protein expression in cultured liver parenchymal and FAO hepatoma cells by PI-3 kinase- and ERK-dependent mechanisms, respectively. In vivo data showed that transporter protein levels were low in livers from TNFRI knock-out mice, but not in those from IL-6 deficient animals. However, IL-6 administration only partiallyrestored CNT1 expression in the former model. CONCLUSIONS: This study identifies TNF-alpha as a major in vivo modulator of the nucleoside transporter CNT1 and suggests a secondary role for IL-6 in mediating CNT1 up-regulation by TNF-alpha in vivo. Evidence is provided that two independent pathways are involved in the up-regulation of CNT1 by TNF-alpha and IL-6.
机译:背景/目的:嘧啶核苷的高亲和力转运蛋白核苷转运蛋白1(CNT1)负责其Na(+)依赖性肝细胞的集中摄取。尽管部分肝切除术后不久大鼠肝脏中的CNT1蛋白含量增加,但尚未确定CNT1表达的生理调节因子。方法:从大鼠和成年大鼠中分离出大鼠肝癌细胞系和肝细胞,以鉴定能够上调CNT1在肝中的表达和活性的单一药物。 TNF-α受体-I(TNFRI)和IL-6敲除小鼠也用于研究CNT1体内调节。结果:TNF-α和IL-6分别通过PI-3激酶和ERK依赖性机制独立诱导培养的肝实质细胞和FAO肝癌细胞中CNT1蛋白的表达。体内数据显示,TNFRI基因敲除小鼠肝脏中的转运蛋白水平较低,但IL-6缺陷动物肝脏中的转运蛋白水平较低。但是,IL-6给药仅能部分恢复前者模型中的CNT1表达。结论:本研究确定TNF-α是核苷转运蛋白CNT1的主要体内调节剂,并提示IL-6在体内通过TNF-α介导CNT1上调具有次要作用。有证据表明,TNF-α和IL-6上调CNT1涉及两个独立的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号